Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
AFT Pharmaceuticals Ltd (ASX:AFP)has outperformed its financial targets for the 2025 fiscal year, delivering$208 million in operating revenue—a 6% year-on-year increase and a significant milestone for the company. As AFT looks ahead, it has now set its sights on a more ambitious target:reaching $300 …
Shares in Mayne Pharmaceuticals (ASX:MYX) plummeted 29.78% to AU$4.55 in morning trade on Wednesday after Cosette Pharmaceuticals, its prospective acquirer, raised concerns about a possible “material adverse change” in Mayne’s financial condition, threatening to withdraw from the AU$672 million takeover deal.
ResMed Inc. (ASX: RMD) based in San Diego, is a global medical device company listed on the NYSE and ASX, specializing in sleep apnoea therapy and digital respiratory health solutions. The Shares of ResMed Inc. (ASX: RMD) declined 5% to A$36.90 on Tuesday after …
Amplia Therapeutics (ASX:ATX) soared 58% on Thursday after announcing a major milestone in its Phase 1b/2a ACCENT clinical trial for pancreatic cancer. The trial, evaluating its FAK inhibitor narmafotinib combined with chemotherapy, has now recorded 15 confirmed partial responses (PRs).
Shares ofPolyNovo Ltd (ASX:PNV)surged as much as14.7% on Tuesday, reachingAU$1.675, following a groundbreaking announcement regarding the company’s NovoSorb BTM (Biodegradable Temporising Matrix) technology and its application in treatingType 1 diabetes.
Orthocell Ltd (ASX:OCC)continues to boost its global footprint with thelatest regulatory milestonefor its flagship nerve repair device,Remplir™, securing approval fromHong Kong’s Department of Health Medical Device Division. The greenlight allows Orthocell to officially commence sales in the strategically significant Hong Kong market—widely recognised as …
Healius Ltd (ASX:HLS) shares are experiencing a sharp sell-off today, plunging 30% to a 52-week low of $1.07 in morning trade, as the stock goes ex-dividend for a special payout.
Pro Medicus Limited [ASX:PME] has announced a landmark A$20 million, five-year contract with University of Iowa Health Care (UI Health Care), marking a significant expansion of its presence in the U.S. healthcare technology market. The agreement will see the full deployment of the Visage …
MedAdvisor Limited (ASX:MDR)has confirmed it has received anon-binding Letter of Intent (LOI)from a major multinational listed software company to acquire its Australia and New Zealand (ANZ) business division. The offer—still confidential in detail—includes acash considerationthat the MedAdvisor board believes represents asignificant premiumover its current …
Healius Ltd (ASX:HLS) shares surged on Monday, defying broader market weakness after the company unveiled plans to reward shareholders with a substantial special dividend. The move comes in the wake of the successful divestment of its Lumus Imaging business, unlocking significant capital for the …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…